23680-12-8

Usage

Uses

Used in Pharmaceutical Industry:
N,N'-(4,5-dinitro-1,2-phenylene)bis(4-methylbenzenesulfonamide) is used as a therapeutic agent for its antimicrobial, antifungal, and antitumor activities, showing potential in the treatment of various diseases.
Used in Organic Synthesis:
N,N'-(4,5-dinitro-1,2-phenylene)bis(4-methylbenzenesulfonamide) is used as a reagent in organic synthesis, contributing to the development of new chemical compounds.
Used in Molecular Assembly:
N,N'-(4,5-dinitro-1,2-phenylene)bis(4-methylbenzenesulfonamide) is used as a building block for the assembly of complex molecular structures, enabling the creation of advanced functional materials.
Safety Note:
Due to its toxic and irritant properties, DNPMBS should be handled with care to ensure safety during its use in various applications.

Upstream product

• 29420-81-3 4,5-dinitro-N¹,N²-ditosyl-o-phenylenediamine 
• 49633-28-5 1,2-bis-(p-methylphenylsulfonamido)-benzene 
• 95-54-5 1,2-diamino-benzene 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 619326-07-7 6',7'-bis[p-tolylsulfonamido]-quinoxaline-[2',3'-d]-1,10-phenanthroline-[5,6] 
• 916220-56-9 N,N'-(2,3-diphenylquinoxaline-6,7-diyl)bis(4-methylbenzenesulfonamide) 
• 1226759-41-6 C₆₄H₅₈N₈O₈S₄ 
• 1226759-40-5 C₄₄H₄₂N₄O₄S₂ 
• 1352399-48-4 5,6-di(p-toluenesulfonamido)-2-(pyridin-2-yl)-1H-benzimidazole 
• 1354638-95-1 2-(pyridin-2-yl)-6,7-diphenyl-1H-imidazo[4,5-g]quinoxaline 
• 1346576-96-2 2,3-bis(4'-butoxy-1',4-biphen-1-yl)-7,8-bis(5'-hexyl-2',5-bithien-2-yl)pyrazino[2,3-g]quinoxaline 
• 1346576-99-5 2,3-bis(4'-butoxy-1',4-biphen-1-yl)-7,8-bis(p-toluenesulfonamido)phenazine 
• 1357090-54-0 C₅₈H₇₄N₄O₄S₂ 
• 1334423-99-2 2,3-didodecanoxy-7,8-ditosylaminophenazine 
• 1334423-98-1 2,3-dihydroxy-7,8-ditosylaminophenazine 
• 1217433-91-4 2,3-(p-toluenesulfonamido)-8,9-dibromo-5,12-dihydro-5,12-diazatetracene di-n-octylimide 

Relevant academic research and scientific papers

Anion sensors based on β,β′-disubstituted porphyrin derivatives

The synthesis of a disulfonamide appended porphyrin receptor (1) for anionic guests is presented. The distinct attribute of the receptor, compared to other porphyrin based receptors, centers on the attachment of the anion binding site to the porphyrin chr

Long-lived, directional photoinduced charge separation in RuII complexes bearing laminate polypyridyl ligands

RuII complexes incorporating both amide-linked bithiophene donor ancillary ligands and laminate acceptor ligands; dipyrido[3,2-a:2′, 3′-c]phenazine (dppz), tetrapyrido[3,2-a:2′,3′-c: 3′′,2′′-h:2′′′,3′′′- j]phenazine (tpphz), and 9,11,20,22-tetr

Synthesis and photophysics of a red-light absorbing supramolecular chromophore system

In search of supramolecular antenna systems for light-harvesting applications, we report on a short and effective synthesis of a fused NDI-zinc-salphen-based chromophore (salphen = bis-salicylimide phenylene) and its photophysical properties. A supramolec

DNA-binding and photocleavage studies of ruthenium(II) complexes containing asymmetric intercalative ligand

A novel asymmetric ligand 2-(pyridine-2-yl)-1-H-imidazo[4,5-i]dibenzo[2,3- a:2′,3′-c]phenazine (pidbp) and its ruthenium complexes [Ru(L) 2(pidbp)]2+ (L = bpy (2, 2′- bipyridine), phen (1, 10 - phenanthroline)), have been synthesized

DERIVATIVES OF PHENAZINE USEFUL TO TREAT CANCER

The present invention relates to derivatives of phenazine having a general formula (I) for use as an agent for treating cancer.

Derivatives of phenazine useful to treat cancer

The present invention relates to derivatives of phenazine having a general formula (I) as follows: for use as an agent for treating cancer.

Substituent effect on the electronic properties of pyrazino[2,3-g] quinoxaline molecules

We report the synthesis and characterization of pyrazino[2,3-g]quinoxaline derivatives with a systematic change in the substituents at the 2, 3, 7 and 8 positions and with or without 2-thienyl at the 5 and 10 positions to study the substituent effect and quinoid character of such a system. We performed density functional theory calculations using the B3LYP functional and 6-31G* basis set under the geometry optimization condition, together with the resonance effect of a valence bond theory to understand the electronic structures of these molecules. It was found that a combination of conjugation and cross-conjugation effects is responsible for the observed trends in their electronic properties, thus giving insights into designing molecules utilizing such effects.

Novel quinoxalinophenanthrophenazine-based molecules as sensors for anions: synthesis and binding investigations

The design and synthesis of two novel quinoxalinophenanthrophenazine-based anion sensors are reported. Binding studies of these sensors with an array of mono- and polyatomic anions using UV-vis, fluorescence, and NMR titrations have shown 1:1 and 1:2 sens

A core-substituted naphthalene diimide fluoride sensor

"Chemical Equation Presented" The synthesis and characterization of a highly fluorescent core-substituted naphthalene diimide sensor (φ = 0.34) bearing a bis-sulfonamide group is described. The compound shows a unique selectivity and reactivity for the fl

Synthesis of amino- and bis(bromomethyl)-substitued bi- and tetradentate N-heteroaromatic ligands: Building blocks for pyrazino-functionalized fullerene dyads

In this paper we describe the synthesis of amino- and bis(bromomethyl)- substituted derivatives of phenanthrofine (phen), pyrazino[2,3-f]-phenanthroline (pphen), dipyrido[3,2-a:2′,3′-c]phenazine (dppz), pyrazino[2,3-i]dipyrido[3,2-a:2′,3′-c]phenazine, 2,3-bis(2-pyridyl)pyrazine (dpp), 2,3-bis(2-pyridyl)quinoxaline (dpq) and 7,8-bis(2-pyridyl)pyrazino[2,3-g]quinoxaline. These substituted bi- and tetradentate N-heteroaromatic ligands are potential synthons for the preparation of the fullerene ligands 4-9. The diketones, 1,10-phenanthroline-5,6-dione 11a (phendione), 2,2-pyridyl 11b and 1,4-dibromo-2,3-butanedione 33 were used as starting materials. Phendione was converted into the phendiamine 13 by a two-step synthesis via the dioxime of the diketone 11a. Amino-substituted dppz and dpq derivatives were obtained by the reduction of the corresponding nitro compounds that were obtained by the Schiff base condensation of the diketones 11a and 11b and the appropriate o-phenylenediamine derivatives. An alternative synthetic route to the diamines 20a and 20b by detosylation of the diamino-substituted dppz and dpq ligands is also presented. Synthesis of the bis(bromomethyl)-substituted pphen, dpp, dppz and dpq derivatives was performed by the photochemical addition of bromine. Alternatively, synthesis of the bis(bromomethyl)-substituted pphen, pdppz and pdpq is also possible by the condensation of 1,4-dibromo-2,3-butanedione 33 and phendiamine or the diamino-substituted dppz and dpq derivatives. The latter two compounds can be also prepared by the condensation of diketones 11a and 11b with 6,7-diamino-2,3-bis(bromomethyl)-quinoxaline. Although the synthesis of some dppz and dpq ligands is already published, we herein present improved or alternative synthetic strategies leading to higher yields and/ or higher purity of these N-heteroaromatic ligands. Wiley-VCH Verlag GmbH & Co. KGaA, 2006.